Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy

PURPOSE: Many effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed, but a weaker response in individuals undergoing anticancer treatment has been reported. This study evaluates the immunogenic status and safety of SARS-CoV-2 vaccines for patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishikubo, Megumi, Tanaka, Yugo, Mitsui, Suguru, Doi, Takefumi, Hokka, Daisuke, Hojo, Wataru, Sakai, Hironori, Funakoshi, Yohei, Yakushijin, Kimikazu, Ohji, Goh, Minami, Hironobu, Maniwa, Yoshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907870/
https://www.ncbi.nlm.nih.gov/pubmed/36752867
http://dx.doi.org/10.1007/s00595-023-02649-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907870/
https://www.ncbi.nlm.nih.gov/pubmed/36752867
http://dx.doi.org/10.1007/s00595-023-02649-1

Ejemplares similares